MCAM and gastric adenocarcinoma: Recent work also showed that the expression levels of MUC14/EMCN, MUC18/MCAM, and MUC15 individually showed significant correlations with worse overall survival in stomach adenocarcinoma (STAD) from TCGA dataset [27] suggesting that these genes could also be prognostic biomarkers in other digestive cancers.